The Janus kinase 1 (JAK1) inhibitor PF-04965842 reduces signs and symptoms of moderate to severe atopic dermatitis (AD)

Gooderham, M; Forman, S; Bissonnette, R; Beebe, J; Zhang, W; Banfield, C; Zhu, L; Papacharalambus, J; Vincent, M; Peeva, E

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018; 138 (5): S94